Nevertheless, this lack of efficacy mirrors our previous findings of a lack of antidyskinetic efficacy in this marmoset model using the mGlu4 orthosteric agonist LSP1-2111 which rather showed a significant increase in chorea [19]. This evidence concerns the gene GRM4 and choreatic disease.